News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sinopharm IPO to Raise up to $1.13 Billion
September 4, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- China's largest pharmaceutical products distributor, Sinopharm Group Co Ltd, is set to raise up to HK$8.73 billion ($1.13 billion) in an initial public offering of shares in Hong Kong, according to a term sheet seen by Reuters on Friday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Asia
MORE ON THIS TOPIC
Podcast
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
April 1, 2026
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy
March 31, 2026
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
Lilly Wakes Up Sleep Market With $6.3B Centessa Buy To Challenge Takeda
March 31, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
After Missing Kezar Buyout in 2024, Tang Returns as CEO of Aurinia With $50M Offer
March 30, 2026
·
2 min read
·
Annalee Armstrong